title: Normalization of haemostatic alterations in overweight children with weight loss due to lifestyle intervention.
abstract: BACKGROUND
  Obesity has been shown to be associated with a hypercoagulable state. However, the effect of weight loss on these haemostatic alterations has not been studied yet with an overall function test such as the thrombin generating test (TG) in obese children.
  
  
  METHODS
  We prospectively determined weight status as SDS-BMI, fibrinogen, and performed TG determining time to peak (TTPeak), peak, time preceding the thrombin burst (lag-time), and "endogenous" thrombin potential (ETP) in 27 overweight children (mean age 11.9 ± 2.4 years, 45% female, mean BMI 27.5 ± 5.6 kg/m(2), mean SDS-BMI 2.31 ± 0.48) both at baseline and after 1 year lifestyle intervention based on nutrition education, exercise therapy, and psychological care. Furthermore, thrombin generating test and fibrinogen were determined in 50 healthy children of same age.
  
  
  RESULTS
  Overweight children demonstrated significantly higher fibrinogen levels (p = 0.013), shorter lag-time (p < 0.001), and TTPeak (p = 0.028) compared to normal-weight children. ETP (p < 0.001) and peak (p < 0.001) were significantly higher in overweight than in normal-weight children. The overweight children reduced their degree of overweight significantly (-0.4 5 ± 0.22 SDS-BMI; p < 0.001). At the end of the lifestyle intervention, all haemostatic alterations normalized (significant decrease of fibrinogen (p = 0.036), ETP (p = 0.034), and peak (p = 0.001); significant increase of lag-time (p = 0.040) and TTPeak (p < 0.001)).
  
  
  CONCLUSIONS
  The alterations in the haemostatic system in obese children normalized after weight loss due to lifestyle intervention demonstrating their reversibility.
authors.affiliation: Department of Pediatrics, Medical University of Graz, Austria.
authors.forename: P
authors.initials: P
authors.lastname: Fritsch
authors.forename: M
authors.initials: M
authors.lastname: Kleber
authors.forename: A
authors.initials: A
authors.lastname: Schlagenhauf
authors.forename: B
authors.initials: B
authors.lastname: Laschnik
authors.forename: M
authors.initials: M
authors.lastname: Fritsch
authors.forename: W
authors.initials: W
authors.lastname: Muntean
authors.forename: H
authors.initials: H
authors.lastname: Mangge
authors.forename: T
authors.initials: T
authors.lastname: Reinehr
mesh_terms: D000293:Adolescent; D001521:Behavior Therapy; D001780:Blood Coagulation Tests; D015992:Body Mass Index; D016009:Chi-Square Distribution; D002648:Child; D004038:Diet, Reducing; D005081:Exercise Therapy; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D005858:Germany; D006487:Hemostasis; D006801:Humans; D008297:Male; D050177:Overweight / Q000097:blood / Q000150:complications / Q000628:therapy*; D011446:Prospective Studies; D040242:Risk Reduction Behavior; D013917:Thrombin / Q000378:metabolism; D019851:Thrombophilia / Q000097:blood / Q000209:etiology / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome; D015431:Weight Loss
chemical_list: D005340:Fibrinogen; D013917:Thrombin